EHR Triggers Cut Time to Diagnostic Cancer Evaluation

This article originally appeared here.
Share this content:
EHR Triggers Cut Time to Diagnostic Cancer Evaluation
EHR Triggers Cut Time to Diagnostic Cancer Evaluation

FRIDAY, Sept. 18, 2015 (HealthDay News) -- Electronic health record-based triggers may cut time to diagnostic evaluation of colorectal and prostate cancer, according to a study published online Aug. 24 in the Journal of Clinical Oncology.

Daniel R. Murphy, M.D., from the Michael E. DeBakey Veterans Affairs Medical Center in Houston, and colleagues tested whether prospective use of electronic health record-based trigger algorithms to identify patients at risk of diagnostic delays could prevent delays in diagnostic evaluation for lung, colorectal, or prostate cancer. The intervention (April 20, 2011, to July 19, 2012) included queries of the electronic health record repository for patients with abnormal findings and lack of associated follow-up actions, manual review of triggered records, and communication of this information to primary care providers (36 providers each in the intervention and control group) via secure e-mail and, if needed, phone calls.

The researchers found that of 10,673 patients with abnormal findings, the trigger flagged 1,256 patients (11.8 percent) as high risk for delayed diagnostic evaluation. Among patients seen by primary care providers in the intervention group with a trigger for colorectal or prostate cancer, times to diagnostic evaluation were significantly lower compared with control patients. This was not true for patients with a lung cancer trigger.

"Electronic trigger-based interventions seem to be effective in reducing time to diagnostic evaluation of colorectal and prostate cancer as well as improving the proportion of patients who receive follow-up," conclude the authors.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

California Lawsuit Claims AbbVie Paid Doctors to Prescribe Humira

California Lawsuit Claims AbbVie Paid Doctors to Prescribe ...

Claims physicians prescribed Humira because of financial kickbacks, not as best drug for patient

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-controlled remifentanil reduces proportion of conversions versus intramuscular pethidine

Pediatricians Have Role in Supporting Transgender Youth

Pediatricians Have Role in Supporting Transgender Youth

Recommendations developed for comprehensive care for youth identifying as transgender, gender diverse

is free, fast, and customized just for you!




Already a member?

Sign In Now »